These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 34188521)

  • 1. A Two-Stage Study Identifies Two Novel Polymorphisms in
    Xiao D; Liu JY; Zhang SM; Liu RR; Yin JY; Han XY; Li X; Zhang W; Chen XP; Zhou HH; Ji LN; Liu ZQ
    Pharmgenomics Pers Med; 2021; 14():745-755. PubMed ID: 34188521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program.
    Jablonski KA; McAteer JB; de Bakker PI; Franks PW; Pollin TI; Hanson RL; Saxena R; Fowler S; Shuldiner AR; Knowler WC; Altshuler D; Florez JC;
    Diabetes; 2010 Oct; 59(10):2672-81. PubMed ID: 20682687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Metformin on Glycemic Control Regarding Carriers of the
    Zepeda-Carrillo EA; Ramos-Lopez O; Martínez-López E; Barrón-Cabrera E; Bernal-Pérez JA; Velasco-González LE; Rangel-Rios E; Bustamante Martínez JF; Torres-Valadez R
    Diabetes Metab Syndr Obes; 2022; 15():1771-1784. PubMed ID: 35711690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes.
    Dujic T; Bego T; Malenica M; Velija-Asimi Z; Ahlqvist E; Groop L; Pearson ER; Causevic A; Semiz S
    Bosn J Basic Med Sci; 2019 Nov; 19(4):368-374. PubMed ID: 31070566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele frequency and genotype distribution of a common variant in the 3´-untranslated region of the SLC22A3 gene in patients with type 2 diabetes: Association with response to metformin.
    Ghaffari-Cherati M; Mahrooz A; Hashemi-Soteh MB; Hosseyni-Talei SR; Alizadeh A; Nakhaei SM
    J Res Med Sci; 2016; 21():92. PubMed ID: 28163738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA polymorphisms and transcript abundance of PRKAG2 and phosphorylated AMP-activated protein kinase in the rumen are associated with gain and feed intake in beef steers.
    Lindholm-Perry AK; Kuehn LA; Oliver WT; Kern RJ; Cushman RA; Miles JR; McNeel AK; Freetly HC
    Anim Genet; 2014 Aug; 45(4):461-72. PubMed ID: 24730749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of
    Ebid AIM; Ehab M; Ismail A; Soror S; Mahmoud MA
    J Drug Assess; 2019; 8(1):115-121. PubMed ID: 31231590
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequency of
    Cuautle-Rodríguez P; Rodríguez-Rivera N; De Andrés F; Castillo-Nájera F; Llerena A; Molina-Guarneros JA
    Biomed Rep; 2019 May; 10(5):283-295. PubMed ID: 31086662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants associated with lean and obese type 2 diabetes in a Han Chinese population: A case-control study.
    Kong X; Xing X; Hong J; Zhang X; Yang W
    Medicine (Baltimore); 2016 Jun; 95(23):e3841. PubMed ID: 27281091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Association of Solute Carrier Transporter Gene Variants with Metformin Response.
    Abrahams-October Z; Xhakaza L; Pearce B; Mandisa Masilela C; Benjeddou M; Vincent Adeniyi O; Johnson R; Jebio Ongole J
    Balkan J Med Genet; 2021 Jun; 24(1):47-56. PubMed ID: 34447659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 coding genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients.
    Zaharenko L; Kalnina I; Geldnere K; Konrade I; Grinberga S; Židzik J; Javorský M; Lejnieks A; Nikitina-Zake L; Fridmanis D; Peculis R; Radovica-Spalvina I; Hartmane D; Pugovics O; Tkáč I; Klimčáková L; Pīrāgs V; Klovins J
    Eur J Endocrinol; 2016 Dec; 175(6):531-540. PubMed ID: 27609360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes.
    Ma RC; Tam CH; Wang Y; Luk AO; Hu C; Yang X; Lam V; Chan AW; Ho JS; Chow CC; Tong PC; Jia W; Ng MC; So WY; Chan JC
    JAMA; 2010 Aug; 304(8):881-9. PubMed ID: 20736472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant gamma2 subunit of 5'-AMP-activated protein kinase, to human chromosome 7q36.
    Lang T; Yu L; Tu Q; Jiang J; Chen Z; Xin Y; Liu G; Zhao S
    Genomics; 2000 Dec; 70(2):258-63. PubMed ID: 11112354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarbose.
    Chen PH; Tsai YT; Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Sheu WH; Lin SY
    Diabetol Metab Syndr; 2014; 6():68. PubMed ID: 24932223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in organic cation transporter 1 (OCT1) in Chinese and Japanese populations exhibit altered function.
    Chen L; Takizawa M; Chen E; Schlessinger A; Segenthelar J; Choi JH; Sali A; Kubo M; Nakamura S; Iwamoto Y; Iwasaki N; Giacomini KM
    J Pharmacol Exp Ther; 2010 Oct; 335(1):42-50. PubMed ID: 20639304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetic Evaluation of Metformin and Sulphonylurea Response in Mexican Mestizos with Type 2 Diabetes.
    Marta M; Sánchez-Pozos K; Jaimes-Santoyo J; Monroy-Escutia J; Rivera-Santiago C; de Los Ángeles Granados-Silvestre M; Ortiz-López MG
    Curr Drug Metab; 2020; 21(4):291-300. PubMed ID: 32407269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Characterization of Metformin Hepatic Response.
    Luizon MR; Eckalbar WL; Wang Y; Jones SL; Smith RP; Laurance M; Lin L; Gallins PJ; Etheridge AS; Wright F; Zhou Y; Molony C; Innocenti F; Yee SW; Giacomini KM; Ahituv N
    PLoS Genet; 2016 Nov; 12(11):e1006449. PubMed ID: 27902686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels.
    Al-Eitan LN; Almomani BA; Nassar AM; Elsaqa BZ; Saadeh NA
    J Pers Med; 2019 Mar; 9(1):. PubMed ID: 30934600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients.
    Tarasova L; Kalnina I; Geldnere K; Bumbure A; Ritenberga R; Nikitina-Zake L; Fridmanis D; Vaivade I; Pirags V; Klovins J
    Pharmacogenet Genomics; 2012 Sep; 22(9):659-66. PubMed ID: 22735389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patients.
    Umamaheswaran G; Praveen RG; Damodaran SE; Das AK; Adithan C
    Clin Exp Med; 2015 Nov; 15(4):511-7. PubMed ID: 25492374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.